These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2198377)

  • 1. Refractory and relapsing Hodgkin's disease: role of high-dose chemotherapy with bone marrow transplantation.
    Thomas M; Gattermann N; Schneider W
    Klin Wochenschr; 1990 Jun; 68(11):539-44. PubMed ID: 2198377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation in Hodgkin's disease.
    Gisselbrecht C; Brice P; Lepage E; Brichon P; Gerota J; Boiron M
    Nouv Rev Fr Hematol (1978); 1990; 32(1):5-7. PubMed ID: 2190180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.
    Brice P; Gisselbrecht C; Ferme C; Lepage E; Baruchel A; Marolleau JP; Gerota O; Boiron M
    Nouv Rev Fr Hematol (1978); 1991; 33(3):267-72. PubMed ID: 1956765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
    Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U
    Med Klin (Munich); 1992 Nov; 87(11):555-62. PubMed ID: 1281905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease.
    Brandwein JM; Callum J; Sutcliffe SB; Scott JG; Keating A
    Bone Marrow Transplant; 1990 Feb; 5(2):99-103. PubMed ID: 2310878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.
    Armitage JO; Bierman PJ; Vose JM; Anderson JR; Weisenburger DD; Kessinger A; Reed EC; Vaughan WP; Coccia PF; Purtilo DT
    Am J Med; 1991 Dec; 91(6):605-11. PubMed ID: 1750430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.
    Jones RJ; Piantadosi S; Mann RB; Ambinder RF; Seifter EJ; Vriesendorp HM; Abeloff MD; Burns WH; May WS; Rowley SD
    J Clin Oncol; 1990 Mar; 8(3):527-37. PubMed ID: 2307990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
    Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U
    Leuk Lymphoma; 1994 Jun; 14(1-2):79-89. PubMed ID: 7522721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report.
    Carella Am; Carlier P; Congiu A; Occhini D; Meloni G; Anselmo AP; Mandelli F; Mazza P; Tura S; Mangoni L
    Leukemia; 1991; 5 Suppl 1():68-71. PubMed ID: 1890870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of Hodgkin's disease.
    Williams SF; Bitran JD
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):319-30. PubMed ID: 2663830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant.
    Crump M; Smith AM; Brandwein J; Couture F; Sherret H; Sutton DM; Scott JG; McCrae J; Murray C; Pantalony D
    J Clin Oncol; 1993 Apr; 11(4):704-11. PubMed ID: 8478664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease.
    Seymour LK; Dansey RD; Bezwoda WR
    Br J Cancer; 1994 Sep; 70(3):526-30. PubMed ID: 8080741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse.
    Desch CE; Lasala MR; Smith TJ; Hillner BE
    J Clin Oncol; 1992 Feb; 10(2):200-9. PubMed ID: 1531067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation.
    Colwill R; Crump M; Couture F; Danish R; Stewart AK; Sutton DM; Scott JG; Sutcliffe SB; Brandwein JM; Keating A
    J Clin Oncol; 1995 Feb; 13(2):396-402. PubMed ID: 7844600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
    Mundt AJ; Sibley G; Williams S; Hallahan D; Nautiyal J; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):261-70. PubMed ID: 7673013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.
    Taylor PR; Jackson GH; Lennard AL; Lucraft H; Proctor SJ
    Br J Cancer; 1993 Feb; 67(2):383-7. PubMed ID: 8431371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation.
    Gribben JG; Linch DC; Singer CR; McMillan AK; Jarrett M; Goldstone AH
    Blood; 1989 Jan; 73(1):340-4. PubMed ID: 2642715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of autotransplantation in Hodgkin's disease.
    Bierman PJ; Armitage JO
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):591-611. PubMed ID: 8344883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.
    Longo DL; Duffey PL; Young RC; Hubbard SM; Ihde DC; Glatstein E; Phares JC; Jaffe ES; Urba WJ; DeVita VT
    J Clin Oncol; 1992 Feb; 10(2):210-8. PubMed ID: 1732422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's disease.
    Phillips GL; Reece DE; Lerner KG; Connors JM
    Bone Marrow Transplant; 1990 Jul; 6(1):45-7. PubMed ID: 1975204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.